| Issue Date | Title | Author(s) |
| 2015-01-01 | Best supportive care in clinical trials: Review of the inconsistency in control arm design | Nipp, RD; Currow, DC; Cherny, NI; Strasser, F; Abernethy, AP; Zafar, SY |
| 2020-02-01 | Ten-year quality of life outcomes in men with prostate cancer | Ralph, N; Ng, SK; Zajdlewicz, L; Lepore, SJ; Heathcote, P; Kneebone, A; Dunn, JC; Chambers, SK |
| 2017-01-01 | AMDAT Lung, An Ideal Lung Cancer MDT Dataset | Stone, E; Rankin, N; Phillips, J; Fong, K; Miller, A; Largey, G; Zielinski, R; Flynn, P; Currow, D; Shaw, T |
| 2017-01-01 | A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN) | Schloss, JM; Colosimo, M; Airey, C; Masci, P; Linnane, AW; Vitetta, L |
| 2011-03-01 | Australian palliative care providers' perceptions and experiences of the barriers and facilitators to palliative care provision | Johnson, C; Girgis, A; Paul, C; Currow, DC; Adams, J; Aranda, S |
| 2019-04-01 | Five-year outcomes from a randomised controlled trial of a couples-based intervention for men with localised prostate cancer | Chambers, SK; Occhipinti, S; Stiller, A; Zajdlewicz, L; Nielsen, L; Wittman, D; Oliffe, JL; Ralph, N; Dunn, J |
| 2018-05-01 | MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer | Rose, AM; Krishan, A; Chakarova, CF; Moya, L; Chambers, SK; Hollands, M; Illingworth, JC; Williams, SMG; McCabe, HE; Shah, AZ; Palmer, CNA; Chakravarti, A; Berg, JN; Batra, J; Bhattacharya, SS |
| 2012-02-01 | Consensus-based standards for best supportive care in clinical trials in advanced cancer | Zafar, SY; Currow, DC; Cherny, N; Strasser, F; Fowler, R; Abernethy, AP |
| 2013-11-01 | The prevalence and correlates of supportive care needs in testicular cancer survivors: A cross-sectional study | Smith, A; King, M; Butow, P; Luckett, T; Grimison, P; Toner, GC; Stockler, M; Hovey, E; Stubbs, J; Hruby, G; Gurney, H; Turner, S; Alam, M; Cox, K; Olver, I |
| 2018-05-02 | A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment | Hardy, J; Skerman, H; Glare, P; Philip, J; Hudson, P; Mitchell, G; Martin, P; Spruyt, O; Currow, D; Yates, P |
